Page 106 - Vitamin D and Cancer

4 The Epidemiology of Vitamin D and Cancer Risk 93

4. Garland FC, Garland CF, Gorham ED, Young JF (1990) Geographic variation in breast cancer
mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med
19:614–622
5. Lefkowitz ES, Garland CF (1994) Sunlight, vitamin D, and ovarian cancer mortality rates in
US women. Int J Epidemiol 23:1133–1136
6. Schwartz GG, Hulka BS (1990) Is vitamin D deficiency a risk factor for prostate cancer?
(Hypothesis). Anticancer Res 10:1307–1311
7. Hanchette CL, Schwartz GG (1992) Geographic patterns of prostate cancer mortality. Cancer
70:2861–2869
8. Grant WB (2002) An estimate of premature cancer mortality in the US due to inadequate
doses of solar ultraviolet-B radiation. Cancer 94:1867–1875
9. Platz EA, Rimm EB, Willett WC, Kantoff PW, Giovannucci E (2000) Racial variation in
prostate cancer incidence and in hormonal system markers among male health professionals.
J Natl Cancer Inst 92:2009–2017
10. Holick MF (2004) Vitamin D: importance in the prevention of cancers, type 1 diabetes, heart
disease, and osteoporosis. Am J Clin Nutr 79:362–371
11. Hollis BW (2005) Circulating 25-hydroxyvitamin D levels indicative of vitamin D suffi-
ciency: implications for establishing a new effective dietary intake recommendation for vita-
min D. J Nutr 135:317–322
12. Vieth R (2005) The pharmacology of vitamin D, including fortification strategies. In: Feldman
D et al (eds) Vitamin D, 2nd edn. Elsevier Academic Press, Amsterdam, pp 995–1015
13. Garland CF, Comstock GW, Garland FC, Helsing KJ, Shaw EK, Gorham ED (1989)
Serum 25-hydroxyvitamin D and colon cancer: eight-year prospective study. Lancet 2:
1176–1178
14. Tangrea J, Helzlsouer K, Pietinen P et al (1997) Serum levels of vitamin D metabolites and
the subsequent risk of colon and rectal cancer in Finnish men. Cancer Causes Control
8:615–625
15. Feskanich D, Ma J, Fuchs CS et al (2004) Plasma vitamin D metabolites and risk of colorectal
cancer in women. Cancer Epidemiol Biomarkers Prev 13:1502–1508
16. Levine AJ, Harper JM, Ervin CM et al (2001) Serum 25-hydroxyvitamin D, dietary calcium
intake, and distal colorectal adenoma risk. Nutr Cancer 39:35–41
17. Peters U, McGlynn KA, Chatterjee N et al (2001) Vitamin D, calcium, and vitamin D recep-
tor polymorphism in colorectal adenomas. Cancer Epidemiol Biomarkers Prev
10:1267–1274
18. Platz EA, Hankinson SE, Hollis BW et al (2000) Plasma 1, 25-dihydroxy-and 25-hydroxyvi-
tamin D and adenomatous polyps of the distal colorectum. Cancer Epidemiol Biomarkers
Prev 9:1059–1065
19. Grau MV, Baron JA, Sandler RS et al (2003) Vitamin D, calcium supplementation, and
colorectal adenomas: results of a randomized trial. J Natl Cancer Inst 95:1765–1771
20. Braun MM, Helzlsouer KJ, Hollis BW, Comstock GW (1995) Prostate cancer and
prediagnostic levels of serum vitamin D metabolites (Maryland, United States). Cancer
Causes Control 6:235–239
21. Wactawski-Wende J, Kotchen JM, Anderson GL et al (2006) Calcium plus vitamin D supple-
mentation and the risk of colorectal cancer. N Engl J Med 354:684–696
22. Gorham ED, Garland CF, Garland FC et al (2007) Optimal vitamin D status for colorectal
cancer prevention A quantitative meta analysis. Am J Prev Med 32:210–216
23. Wu K, Feskanich D, Fuchs CS, Willett WC, Hollis BW, Giovannucci EL (2007) A nested
case–control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal
cancer. J Natl Cancer Inst 99:1120–1129
24. Otani T, Iwasaki M, Sasazuki S, Inoue M, Tsugane S (2007) Plasma vitamin D and risk of
colorectal cancer: the Japan Public Health Center-Based Prospective Study. Br J Cancer
97:446–451
25. Freedman DM, Looker AC, Chang SC, Graubard BI (2007) Prospective study of serum vita-
min D and cancer mortality in the United States. J Natl Cancer Inst 99:1594–1602